Current perspectives on the role of IL-17 in autoimmune disease
Hisakata YamadaDivision of Host Defense, Medical Institute of Bioregulation, Kyushu University, Fukuoka, JapanAbstract: Until recently, autoimmune diseases had been categorized as either Th1- or Th2-mediated diseases. However, the discovery of a novel subset of helper T cells producing interleukin (...
Guardado en:
Autor principal: | Hisakata Yamada |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9f2ac3dbf9a744499524a784ba40c565 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
por: Ozaki E, et al.
Publicado: (2015) -
Immunology of fibrotic lung disease: managing infections whilst preventing autoimmunity?
por: Thomas Hügle
Publicado: (2011) -
No evidence for activation of TH1 or TH17 pathways in unstimulated peripheral blood mononuclear cells from children with β-cell autoimmunity or T1D
por: Jenny Walldén, et al.
Publicado: (2008) -
The effects of grounding (earthing) on inflammation, the immune response, wound healing, and prevention and treatment of chronic inflammatory and autoimmune diseases
por: Oschman JL, et al.
Publicado: (2015) -
Translational utility of experimental autoimmune encephalomyelitis: recent developments
por: Guerreiro-Cacais AO, et al.
Publicado: (2015)